ASLAN Pharmaceuticals shares are trading lower after the company announced the receipt of a Nasdaq delisting determination.
Portfolio Pulse from Benzinga Newsdesk
ASLAN Pharmaceuticals shares are trading lower following the company's announcement of a Nasdaq delisting determination.
July 15, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ASLAN Pharmaceuticals shares are trading lower after the company announced the receipt of a Nasdaq delisting determination.
The announcement of a Nasdaq delisting determination is a significant negative event for ASLAN Pharmaceuticals, leading to a drop in share price as investors react to the potential removal from a major stock exchange.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100